CB-SEM IMPLEMENTATION IN R AND PYTHON: A REVIEW AND COMPARATIVE STUDY
| Published in: | Journal of Applied Structural Equation Modeling |
|---|---|
| Main Authors: | Souma Kanti Paul, Alpana Taneja, Sadia Riaz, Suchismita Das |
| Format: | Article |
| Language: | English |
| Published: |
Sarawak Research Society (SRS)
2022-01-01
|
| Subjects: | |
| Online Access: | https://drive.google.com/file/d/1kKhP9JREMT5UQXT6VdbPjsiMBv8EeNRB/view?usp=sharing |
Similar Items
CB-SEM vs PLS-SEM comparison in estimating the predictors of investment intention
by: Marija Vuković
Published: (2024-01-01)
by: Marija Vuković
Published: (2024-01-01)
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
by: Marcel Pérez-Morales, et al.
Published: (2025-02-01)
by: Marcel Pérez-Morales, et al.
Published: (2025-02-01)
What Determines Lean Manufacturing Implementation? A CB-SEM Model
by: Tan Ching Ng, et al.
Published: (2018-02-01)
by: Tan Ching Ng, et al.
Published: (2018-02-01)
Editorial: Therapeutic potential of the cannabinoid CB2 receptor
by: Reem Smoum, et al.
Published: (2022-10-01)
by: Reem Smoum, et al.
Published: (2022-10-01)
Lane changing and keeping as mediating variables to investigate the impact of driving habits on efficiency: An EWM‐GRA and CB‐SEM approach with trajectory data
by: Tianshi Wang, et al.
Published: (2024-02-01)
by: Tianshi Wang, et al.
Published: (2024-02-01)
CB1 receptor and psychosis: friend, foe, or both
by: Jagadeesh S. Rao, et al.
Published: (2025-07-01)
by: Jagadeesh S. Rao, et al.
Published: (2025-07-01)
Editorial: Unravelling the role of CB2r in neuropsychiatric diseases
by: Emmanuel S. Onaivi
Published: (2023-03-01)
by: Emmanuel S. Onaivi
Published: (2023-03-01)
Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
by: Antonella Capozzi, et al.
Published: (2021-12-01)
by: Antonella Capozzi, et al.
Published: (2021-12-01)
SELECTION OF THE BEST SEM MODEL TO IDENTIFY FACTORS AFFECTING MARKETING PERFORMANCE IN THE ICT INDUSTRY
by: Zetil Hikmah, et al.
Published: (2023-06-01)
by: Zetil Hikmah, et al.
Published: (2023-06-01)
Effects of stress and self-efficacy on quality of life of mothers with autistic children: Covariance-Based Structural Equation Modeling (CB-SEM) approach
by: Yap Bee Wah, et al.
Published: (2024-04-01)
by: Yap Bee Wah, et al.
Published: (2024-04-01)
Mobile phone dependency and adolescent exercise participation: a CB-SEM and fsQCA study on the roles of self-control, time management, and health awareness
by: Quan Zhang, et al.
Published: (2025-08-01)
by: Quan Zhang, et al.
Published: (2025-08-01)
CC48 a new CB2R agonist/FAAH inhibitor dual drug blocks gastric cancer progression and overcomes paclitaxel resistance
by: Annalisa Schirizzi, et al.
Published: (2025-07-01)
by: Annalisa Schirizzi, et al.
Published: (2025-07-01)
Maternal sevoflurane exposure induces neurotoxicity in offspring rats via the CB1R/CDK5/p-tau pathway
by: Yuxiao Wan, et al.
Published: (2023-01-01)
by: Yuxiao Wan, et al.
Published: (2023-01-01)
Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation
by: Hong Zhu, et al.
Published: (2023-12-01)
by: Hong Zhu, et al.
Published: (2023-12-01)
Efficient Multiple Imputation for Diverse Data in Python and R: MIDASpy and rMIDAS
by: Ranjit Lall, et al.
Published: (2023-10-01)
by: Ranjit Lall, et al.
Published: (2023-10-01)
Endocannabinoid system upregulates the enrichment and differentiation of human iPSC- derived spermatogonial stem cells via CB2R agonism
by: Merve Gizer, et al.
Published: (2025-03-01)
by: Merve Gizer, et al.
Published: (2025-03-01)
Calculating slope gradient variations in the submarine landforms by R and Python statistical libraries
by: Polina Lemenkova
Published: (2019-12-01)
by: Polina Lemenkova
Published: (2019-12-01)
Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP
by: Hoda Ranjbar, et al.
Published: (2023-03-01)
by: Hoda Ranjbar, et al.
Published: (2023-03-01)
Cannabidiol interacts with the FXR/Nrf2 pathway and changes the CB1/CB2 receptors ratio in gentamicin-induced kidney injury in rats
by: Vahideh Hokmabady, et al.
Published: (2023-03-01)
by: Vahideh Hokmabady, et al.
Published: (2023-03-01)
Sex differences in distribution of cannabinoid receptors (CB1 and CB2), S100A6 and CacyBP/SIP in human ageing hearts
by: Żaneta Piotrowska, et al.
Published: (2018-11-01)
by: Żaneta Piotrowska, et al.
Published: (2018-11-01)
Comprehensive Investigation of ANN Algorithms Implemented in MATLAB, Python, and R for Small-Signal Behavioral Modeling of GaN HEMTs
by: Saddam Husain, et al.
Published: (2023-01-01)
by: Saddam Husain, et al.
Published: (2023-01-01)
Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors
by: Shayma El-Atawneh, et al.
Published: (2022-02-01)
by: Shayma El-Atawneh, et al.
Published: (2022-02-01)
Comparative analysis of web applications implemented in: PHP and Python
by: Jakub Zborowski, et al.
Published: (2023-03-01)
by: Jakub Zborowski, et al.
Published: (2023-03-01)
The Neuro-Protective Effects of the TSPO Ligands CB86 and CB204 on 6-OHDA-Induced PC12 Cell Death as an In Vitro Model for Parkinson’s Disease
by: Sheelu Monga, et al.
Published: (2021-11-01)
by: Sheelu Monga, et al.
Published: (2021-11-01)
Paeoniflorin inhibits APEC-induced inflammation in HD11 cells through the NF-κB signaling pathway by activating CB2R
by: Siyang Shen, et al.
Published: (2025-02-01)
by: Siyang Shen, et al.
Published: (2025-02-01)
Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
by: Francesca Gado, et al.
Published: (2022-05-01)
by: Francesca Gado, et al.
Published: (2022-05-01)
Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB<sub>1</sub>/CB<sub>2</sub> Receptor Interaction
by: Battistina Asproni, et al.
Published: (2021-04-01)
by: Battistina Asproni, et al.
Published: (2021-04-01)
GNU Octave and Python Implementation of Shor's r-Algorithm with Adaptive Step Control
by: Petro Stetsyuk, et al.
Published: (2022-11-01)
by: Petro Stetsyuk, et al.
Published: (2022-11-01)
Code Reuse and Modularity in Python
by: William J. Turkel, et al.
Published: (2012-07-01)
by: William J. Turkel, et al.
Published: (2012-07-01)
An extensive comparison of CB-SEM and PLS-SEM for reliability and validity
by: Asyraf Afthanorhan, et al.
Published: (2020-10-01)
by: Asyraf Afthanorhan, et al.
Published: (2020-10-01)
Cannabinoid CB1 Receptor Expression and Localization in the Dorsal Horn of Male and Female Rat and Human Spinal Cord
by: Jessica Parnell, et al.
Published: (2023-07-01)
by: Jessica Parnell, et al.
Published: (2023-07-01)
Role of CB2 cannabinoid receptor in the development of food addiction in male mice
by: A. García-Blanco, et al.
Published: (2023-04-01)
by: A. García-Blanco, et al.
Published: (2023-04-01)
Tumor-derived exosome PPP3CB induce gemcitabine resistance by regulating miR-298/STAT3 in pancreatic cancer
by: Chaojun Wang, et al.
Published: (2024-08-01)
by: Chaojun Wang, et al.
Published: (2024-08-01)
An enquiry to the role of CB1 receptors in neurodegeneration
by: Ignacio Fernández-Moncada, et al.
Published: (2023-08-01)
by: Ignacio Fernández-Moncada, et al.
Published: (2023-08-01)
Novel micellar CB2 receptor agonist with anti-inflammatory action for treating corneal alkali burns in a mouse model
by: Neethi C. Thathapudi, et al.
Published: (2023-12-01)
by: Neethi C. Thathapudi, et al.
Published: (2023-12-01)
In silico analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution
by: Amy L. Cherry, et al.
Published: (2024-02-01)
by: Amy L. Cherry, et al.
Published: (2024-02-01)
Installing Python Modules with pip
by: Fred Gibbs
Published: (2013-05-01)
by: Fred Gibbs
Published: (2013-05-01)
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
by: Michelle Roche, et al.
Published: (2010-08-01)
by: Michelle Roche, et al.
Published: (2010-08-01)
Finitely presentable objects in ${\rm(}Cb\text{-}{\bf Sets}{\rm)}_{_{\rm fs}}$
by: Mahdieh Haddadi, et al.
Published: (2024-07-01)
by: Mahdieh Haddadi, et al.
Published: (2024-07-01)
Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility
by: Piotr Przybycień, et al.
Published: (2022-08-01)
by: Piotr Przybycień, et al.
Published: (2022-08-01)
Similar Items
-
CB-SEM vs PLS-SEM comparison in estimating the predictors of investment intention
by: Marija Vuković
Published: (2024-01-01) -
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
by: Marcel Pérez-Morales, et al.
Published: (2025-02-01) -
What Determines Lean Manufacturing Implementation? A CB-SEM Model
by: Tan Ching Ng, et al.
Published: (2018-02-01) -
Editorial: Therapeutic potential of the cannabinoid CB2 receptor
by: Reem Smoum, et al.
Published: (2022-10-01) -
Lane changing and keeping as mediating variables to investigate the impact of driving habits on efficiency: An EWM‐GRA and CB‐SEM approach with trajectory data
by: Tianshi Wang, et al.
Published: (2024-02-01)
